Abingworth Exceeds Target on Latest Life-Sciences Fund

U.K. life-sciences investor Abingworth said it has closed a new fund with $315 million. The vehicle, Abingworth Bioventures VII LP, exceeded its $300 million target. Placement agent Asante Capital Group helped raise the fund. Abingworth has invested in more than 145 life-sciences companies and raised 12 life-sciences funds since its founding in 1973.


Ricardo Felix is Appointed Partner as Hong Kong Team Grows

We're excited to announce that Asante has recently appointed Ricardo Felix, Head of Asia-Pacific, to Partner.

Asante Capital congratulates its partner on the final closing of Harbert Infrastructure Fund VI (‘HIF VI’)

We are pleased to announce the final closing of Harbert Infrastructure Fund VI ( ‘HIF VI’) on September 30, 2022. HIF VI secured $905 million in fund and related co-investment commitments to invest in HIF VI’s portfolio of North American power and renewable energy opportunities. 

Private-Equity Firms Look to Foreign Cash as U.S. Pension Funds Struggle

One of our Managing Partners, Fraser van Rensburg, was quoted in a Wall Street Journal article by Chris Cumming about American private-equity firms collecting more money from abroad.